Persistent ex vivo low number and functional in vitro recovery of circulating gammadelta T cells after removal of a cutaneous primary melanoma

• Published in: Scandinavian journal of immunology Vol. 72; no. 2; p. 142
• Main Authors: Provinciali, M, Re, F, Tucci, M G, Ricotti, F, Lattanzio, F
• Format: Journal Article
• Language: English
• Published: England 01.08.2010
• Subjects: Adult; Aged; Aged, 80 and over; Follow-Up Studies; Humans; In Vitro Techniques; Interferon-gamma - blood; Interferon-gamma - immunology; Linear Models; Lymphocyte Activation - immunology; Lymphocyte Count; Melanoma - blood; Melanoma - immunology; Melanoma - surgery; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta - immunology; Skin Neoplasms - blood; Skin Neoplasms - immunology; Skin Neoplasms - surgery; T-Lymphocytes - cytology; T-Lymphocytes - immunology; Tumor Necrosis Factor-alpha - blood; Tumor Necrosis Factor-alpha - immunology
• ISSN: 1365-3083; 1365-3083
• DOI: 10.1111/j.1365-3083.2010.02413.x

We recently described gammadelta T cells alterations in patients with a cutaneous primary melanoma. To evaluate whether gammadelta T cells alterations persisted after melanoma removal, we performed a follow-up study comparing the number and function of gammadelta T lymphocytes from 19 subjects, 4 years after the removal of a cutaneous primary melanoma, with the data obtained in the same subjects before the surgical intervention and with control donors. The number of circulating gammadelta(+) T cells after melanoma removal was not recovered to the levels found in controls. gammadelta(+) T cells producing TNF-alpha or IFN-gamma were increased after melanoma removal in comparison with the same subjects before surgical intervention or with control donors. After in vitro culture, both the percentage and the expansion of gammadelta T cells were recovered to the values found in controls. In conclusion, the functional capacity of gammadelta T cells was in vitro recovered after melanoma removal, whereas their ex vivo number remained at lower levels than control donors.